BRIEF published on 11/28/2025 at 07:05, 7 days 1 hour ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
BRIEF published on 11/28/2025 at 07:05, 7 days 1 hour ago Nouveau nombre d'actions et droits de vote d'Innate Pharma Euronext Paris Capital Social Nasdaq Innate Pharma Actions Et Droits
PRESS RELEASE published on 11/28/2025 at 07:00, 7 days 1 hour ago Informations privilégiées / Autres communiqués Innate Pharma communique le nouveau nombre d'actions et de droits de vote au 27 novembre 2025 selon la réglementation en vigueur avec 92 196 523 actions ordinaires et 92 962 943 droits de vote théoriques Droits De Vote Actions AMF Innate Pharma Biotechnologies
BRIEF published on 11/17/2025 at 07:05, 18 days 1 hour ago Innate Pharma présentera ses travaux lors de la conférence mondiale sur les soins de santé de Jefferies. Biotechnologie Immunothérapie Innate Pharma Conférence Jefferies Thérapeutiques Par Anticorps
BRIEF published on 11/17/2025 at 07:05, 18 days 1 hour ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
PRESS RELEASE published on 11/17/2025 at 07:00, 18 days 1 hour ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
PRESS RELEASE published on 11/17/2025 at 07:00, 18 days 1 hour ago Informations privilégiées / Autres communiqués Innate Pharma présentera lors de la Jefferies Global Healthcare Conference à Londres le 17 novembre 2025. La société développe des traitements d'immunothérapies contre le cancer Société Cancer Innate Pharma Jefferies Global Healthcare Conference Immunothérapies
BRIEF published on 10/14/2025 at 07:05, 1 month 22 days ago Innate Pharma met en avant lacutamab lors d'un événement analystes et investisseurs Investisseurs Essai Clinique Innate Pharma Lacutamab Syndrome De Sézary
BRIEF published on 10/14/2025 at 07:05, 1 month 22 days ago Innate Pharma Highlights Lacutamab at Analyst and Investor Event Investors Clinical Trial Innate Pharma Lacutamab Sézary Syndrome
PRESS RELEASE published on 10/14/2025 at 07:00, 1 month 22 days ago Informations privilégiées / Autres communiqués Innate Pharma organise un événement analystes et investisseurs dédié à Lacutamab le 28 octobre 2025, mettant en lumière les perspectives cliniques et commerciales du produit Investisseurs Événement Innate Pharma Analystes Lacutamab
Published on 12/05/2025 at 02:35, 5 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:05, 19 minutes ago Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 24 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 24 minutes ago Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 24 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 24 minutes ago Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions
Published on 12/04/2025 at 18:14, 14 hours 10 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
